MITOZYTREX vs VIVIMUSTA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. MITOZYTREX and VIVIMUSTA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MITOZYTREX	VIVIMUSTA
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	MITOMYCIN	BENDAMUSTINE HYDROCHLORIDE
Manufacturer	Supergen	Azurity
Dosage forms	Injectable	Injectable
Drug class	Alkylating Drug	Alkylating Drug
Boxed warning	None	None
Treats	Adenocarcinoma, Urinary Bladder Neoplasms, Pancreatic Neoplasms	Lymphoid Leukemia, Non-Hodgkin Lymphoma

mitozytrex vivimusta

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

MITOMYCIN

BENDAMUSTINE HYDROCHLORIDE

Manufacturer

Supergen

Azurity

Dosage forms

Injectable

Drug class

Alkylating Drug

Boxed warning

None

Treats

Adenocarcinoma, Urinary Bladder Neoplasms, Pancreatic Neoplasms

Lymphoid Leukemia, Non-Hodgkin Lymphoma

Frequently asked questions

What is the difference between Mitozytrex and Vivimusta?

Mitozytrex contains Mitomycin, while Vivimusta contains Bendamustine Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.